The current study identified higher levels of WBC, ESR, CRP, and IL‐10 as inflammatory markers that are correlated with the severity of COVID‐19, hence, measuring these markers may speed early recognition of the disease progression and could be significant in their clinical treatments. This evidence concerns the gene ESR1 and COVID-19.